WEBULL
News
ELTP
0.500
+7.07%
0.033
Weekly Report: what happened at ELTP last week (1222-1226)?
Weekly Report · 12/29/2025 09:34
Weekly Report: what happened at ELTP last week (1215-1219)?
Weekly Report · 12/22/2025 09:34
Weekly Report: what happened at ELTP last week (1208-1212)?
Weekly Report · 12/15/2025 09:37
Weekly Report: what happened at ELTP last week (1201-1205)?
Weekly Report · 12/08/2025 09:37
Weekly Report: what happened at ELTP last week (1124-1128)?
Weekly Report · 12/01/2025 09:34
Weekly Report: what happened at ELTP last week (1117-1121)?
Weekly Report · 11/24/2025 09:37
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
NASDAQ · 11/19/2025 16:37
Elite Pharmaceuticals’ Earnings Call Highlights Robust Growth Amid Challenges
TipRanks · 11/19/2025 00:10
Elite Pharmaceuticals Reports Strong Financial Turnaround
TipRanks · 11/18/2025 03:58
Weekly Report: what happened at ELTP last week (1110-1114)?
Weekly Report · 11/17/2025 09:37
Elite Pharmaceuticals Reports 92% Revenue Growth in Q2
TipRanks · 11/14/2025 22:33
Elite Pharmaceuticals Reports 92% Revenue Increase for Fiscal Q2 2026
Reuters · 11/14/2025 21:19
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
Newsfile · 11/14/2025 21:19
Elite Pharmaceuticals Gains FDA Approval for Generic Drug
TipRanks · 11/12/2025 12:54
Elite Pharmaceuticals Receives FDA Approval for Generic Requip XL
Reuters · 11/12/2025 12:02
Elite Pharmaceuticals to Release Q2 2026 Results Soon
TipRanks · 11/10/2025 12:51
Elite Pharmaceuticals Inc. to Release Second Quarter 2026 Financial Results
Reuters · 11/10/2025 12:04
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
Newsfile · 11/10/2025 12:00
Weekly Report: what happened at ELTP last week (1103-1107)?
Weekly Report · 11/10/2025 09:36
Weekly Report: what happened at ELTP last week (1027-1031)?
Weekly Report · 11/03/2025 09:35
More
Webull provides a variety of real-time ELTP stock news. You can receive the latest news about Elite Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About ELTP
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.